HU201875B - Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid - Google Patents
Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid Download PDFInfo
- Publication number
- HU201875B HU201875B HU874311A HU431187A HU201875B HU 201875 B HU201875 B HU 201875B HU 874311 A HU874311 A HU 874311A HU 431187 A HU431187 A HU 431187A HU 201875 B HU201875 B HU 201875B
- Authority
- HU
- Hungary
- Prior art keywords
- process according
- microcrystalline cellulose
- weight
- hydroxypropyl
- methylcellulose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868624213A GB8624213D0 (en) | 1986-10-09 | 1986-10-09 | Sustained release pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT52958A HUT52958A (en) | 1990-09-28 |
| HU201875B true HU201875B (en) | 1991-01-28 |
Family
ID=10605478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU874311A HU201875B (en) | 1986-10-09 | 1987-09-25 | Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS63101334A (fr) |
| KR (1) | KR880004801A (fr) |
| AU (1) | AU7942087A (fr) |
| BE (1) | BE1000732A5 (fr) |
| CA (1) | CA1332809C (fr) |
| CH (1) | CH675831A5 (fr) |
| DE (1) | DE3733540A1 (fr) |
| DK (1) | DK527487A (fr) |
| ES (1) | ES2014518A6 (fr) |
| FI (1) | FI874414A (fr) |
| FR (1) | FR2604902B1 (fr) |
| GB (2) | GB8624213D0 (fr) |
| GR (1) | GR871550B (fr) |
| HU (1) | HU201875B (fr) |
| IL (1) | IL84104A0 (fr) |
| IT (1) | IT1221493B (fr) |
| LU (1) | LU87009A1 (fr) |
| NL (1) | NL8702294A (fr) |
| NO (1) | NO874200L (fr) |
| NZ (1) | NZ222083A (fr) |
| PH (1) | PH24227A (fr) |
| PT (1) | PT85880B (fr) |
| SE (1) | SE8703889L (fr) |
| ZA (1) | ZA877617B (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5948437A (en) * | 1996-05-23 | 1999-09-07 | Zeneca Limited | Pharmaceutical compositions using thiazepine |
| US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
| CA2371940C (fr) * | 1999-03-31 | 2008-07-15 | Janssen Pharmaceutica N.V. | Amidon pregelatinise dans une formulation a liberation regulee |
| US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
| US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
| SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
| TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
| SI1803447T1 (sl) * | 2004-09-09 | 2010-01-29 | Psicofarma S A De C V | Farmacevtski sestavek za zadrĺ˝evano sproĺ äśanje hidralazina in njegova uporaba kot podrpora zdravljenju raka |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
| US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
| US4520009A (en) * | 1983-11-28 | 1985-05-28 | Verex Laboratories, Inc. | Sustained released aspirin formulation |
| DE3346571A1 (de) * | 1983-12-23 | 1985-07-04 | Bayer Ag, 5090 Leverkusen | Oral retardierte acetylsalicylsaeureformulierungen |
| JPS61501511A (ja) * | 1984-03-21 | 1986-07-24 | アメリカン・ホ−ム・プロダクツ・コ−ポレイション | 徐放性医薬カプセル |
-
1986
- 1986-10-09 GB GB868624213A patent/GB8624213D0/en active Pending
-
1987
- 1987-09-25 NL NL8702294A patent/NL8702294A/nl not_active Application Discontinuation
- 1987-09-25 HU HU874311A patent/HU201875B/hu not_active IP Right Cessation
- 1987-10-02 BE BE8701131A patent/BE1000732A5/fr not_active IP Right Cessation
- 1987-10-02 FR FR878713759A patent/FR2604902B1/fr not_active Expired - Lifetime
- 1987-10-02 CH CH3838/87A patent/CH675831A5/de not_active IP Right Cessation
- 1987-10-03 DE DE19873733540 patent/DE3733540A1/de not_active Withdrawn
- 1987-10-06 KR KR870011168A patent/KR880004801A/ko not_active Application Discontinuation
- 1987-10-06 LU LU87009A patent/LU87009A1/fr unknown
- 1987-10-06 IL IL84104A patent/IL84104A0/xx unknown
- 1987-10-07 NZ NZ222083A patent/NZ222083A/en unknown
- 1987-10-07 GB GB8723515A patent/GB2195893B/en not_active Expired - Lifetime
- 1987-10-07 GR GR871550A patent/GR871550B/el unknown
- 1987-10-07 FI FI874414A patent/FI874414A/fi not_active IP Right Cessation
- 1987-10-07 PT PT85880A patent/PT85880B/pt not_active IP Right Cessation
- 1987-10-07 NO NO874200A patent/NO874200L/no unknown
- 1987-10-07 AU AU79420/87A patent/AU7942087A/en not_active Abandoned
- 1987-10-08 IT IT48469/87A patent/IT1221493B/it active
- 1987-10-08 ES ES8702873A patent/ES2014518A6/es not_active Expired - Lifetime
- 1987-10-08 PH PH35906A patent/PH24227A/en unknown
- 1987-10-08 SE SE8703889A patent/SE8703889L/ not_active Application Discontinuation
- 1987-10-08 JP JP62256149A patent/JPS63101334A/ja active Pending
- 1987-10-08 CA CA000548872A patent/CA1332809C/fr not_active Expired - Lifetime
- 1987-10-08 DK DK527487A patent/DK527487A/da not_active Application Discontinuation
- 1987-10-09 ZA ZA877617A patent/ZA877617B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT52958A (en) | 1990-09-28 |
| DK527487D0 (da) | 1987-10-08 |
| FR2604902B1 (fr) | 1991-04-26 |
| ES2014518A6 (es) | 1990-07-16 |
| LU87009A1 (fr) | 1988-05-03 |
| SE8703889D0 (sv) | 1987-10-08 |
| SE8703889L (sv) | 1988-04-10 |
| IT1221493B (it) | 1990-07-06 |
| FI874414A (fi) | 1988-04-10 |
| FI874414A0 (fi) | 1987-10-07 |
| IT8748469A0 (it) | 1987-10-08 |
| DK527487A (da) | 1988-04-10 |
| PH24227A (en) | 1990-05-04 |
| GB2195893B (en) | 1991-05-08 |
| JPS63101334A (ja) | 1988-05-06 |
| GB8723515D0 (en) | 1987-11-11 |
| ZA877617B (en) | 1989-05-30 |
| IL84104A0 (en) | 1988-03-31 |
| PT85880B (pt) | 1990-07-31 |
| GB8624213D0 (en) | 1986-11-12 |
| KR880004801A (ko) | 1988-06-27 |
| CA1332809C (fr) | 1994-11-01 |
| CH675831A5 (fr) | 1990-11-15 |
| PT85880A (en) | 1987-11-01 |
| GB2195893A (en) | 1988-04-20 |
| GR871550B (en) | 1988-02-15 |
| NO874200D0 (no) | 1987-10-07 |
| DE3733540A1 (de) | 1988-04-14 |
| NO874200L (no) | 1988-04-11 |
| AU7942087A (en) | 1988-04-14 |
| BE1000732A5 (fr) | 1989-03-21 |
| NL8702294A (nl) | 1988-05-02 |
| NZ222083A (en) | 1991-05-28 |
| FR2604902A1 (fr) | 1988-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4556678A (en) | Sustained release propranolol tablet | |
| CA2285266C (fr) | Formulations a liberation prolongee de derives d'erythromycine | |
| US6872407B2 (en) | Extended release formulations of erythromycin derivatives | |
| AU2009326084B2 (en) | Ulipristal acetate tablets | |
| CA2289260C (fr) | Medicaments a liberation controlee administres par voie sublinguale ou buccale | |
| AU2004275469B2 (en) | HRT formulations | |
| US20080221213A1 (en) | Tablets Comprising a High Load of Strontium | |
| CZ227595A3 (en) | Pharmaceutical preparation and oral dosing forms | |
| MXPA05006513A (es) | Farmaco solido para uso oral. | |
| HU201875B (en) | Process for producing retarde pharmaceutical compositions containing acetyl-salicylic acid | |
| US20050064033A1 (en) | Extended release formulations of erythromycin derivatives | |
| JP2008534621A (ja) | リオチロニンからなる放出制御型医薬組成物、並びにその製造方法及び使用方法 | |
| KR101046789B1 (ko) | 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법 | |
| CN106474095B (zh) | 一种用于治疗口腔真菌的口腔粘膜粘贴剂及其制备方法 | |
| HU196121B (en) | Process for production of medical compounds containing brome-cryptin and assuring regulated release of the active substance | |
| AU2003270948B2 (en) | Extended Release Formulations of Erythromycin Derivatives | |
| CA2325541C (fr) | Formulations a liberation prolongee de derives d'erythromycine | |
| AU773863B2 (en) | Extended release formulations of erythromycin derivatives | |
| AU2007201031B2 (en) | Extended release formulations of erythromycin derivatives | |
| Shah Ankurkumar | Formulation and Evaluation of Sustained Release Bilayer Tablets of Glimepiride and Metformin HCl. | |
| CA2465698A1 (fr) | Formulations a liberation prolongee de derives d'erythromycine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HMM4 | Cancellation of final prot. due to non-payment of fee |